Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017536 (
giardiasis
)
1,714
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Giardia lambia
is a flagellated protozoan parasite that lives in the small intestine and is the causal agent of
giardiasis
. It has been reported that
G. lamblia
exhibits glucose-6-phosphate dehydrogenase (G6PD), the first enzyme in the pentose phosphate pathway (PPP). Our group work demonstrated that the
g6pd
and
6pgl
genes are present in the open frame that gives rise to the fused G6PD::
6PGL
protein; where the G6PD region is similar to the 3D structure of G6PD in
Homo sapiens
. The objective of the present work was to show the presence of the structural NADP
+
binding site on the fused G6PD::
6PGL
protein and evaluate the effect of the NADP
+
molecule on protein stability using biochemical and computational analysis. A protective effect was observed on the thermal inactivation, thermal stability, and trypsin digestions assays when the protein was incubated with NADP
+
. By molecular docking, we determined the possible structural-NADP
+
binding site, which is located between the Rossmann fold of G6PD and
6PGL
. Finally, molecular dynamic (MD) simulation was used to test the stability of this complex; it was determined that the presence of both NADP
+
structural and cofactor increased the stability of the enzyme, which is in agreement with our experimental results.
...
PMID:Identification of the NADP
+
Structural Binding Site and Coenzyme Effect on the Fused G6PD::6PGL Protein from
Giardia lamblia
. 3189 24